José E Meca-Lallana (J E Meca-Lallana, José Meca-Lallana, Jose E Meca-Lallana)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Respiratory Syndrome Coronavirus

Spectrum Disorder

Psychometric Properties

Patient Reported

Top Venues

Neurology and therapy

Journal of personalized medicine

Neurodegenerative disease management

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge Millán-Pascual, Gabriel Valero-López, Francisca Iniesta-Martinez, Maria Fuensanta Hellin-Gil, Judith Jimenez-Veiga, Isabel Alejandra López-Tovar, Ana Morales-Ortiz, José E Meca-Lallana
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study. Neurology and therapy (2023)
Jorge Millán-Pascual, Gabriel Valero-López, Francisca Iniesta-Martinez, Maria Fuensanta Hellin-Gil, Judith Jimenez-Veiga, Isabel Alejandra López-Tovar, Ana Morales-Ortiz, José E Meca-Lallana
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study. Neurology and therapy 13 (1) (2023)
Jorge Millán-Pascual, Gabriel Valero-López, Francisca Iniesta-Martinez, Maria Fuensanta Hellin-Gil, Judith Jimenez-Veiga, Isabel Alejandra López-Tovar, Ana Morales-Ortiz, José E Meca-Lallana
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study. Neurology and therapy 13 (1) (2023)
Jorge Millán-Pascual, Gabriel Valero-López, Francisca Iniesta-Martinez, Maria Fuensanta Hellin-Gil, Judith Jimenez-Veiga, Isabel Alejandra López-Tovar, Ana Morales-Ortiz, José E Meca-Lallana
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study. Neurology and therapy 13 (1) (2023)
Jorge Millán-Pascual, Gabriel Valero-López, Francisca Iniesta-Martinez, Maria Fuensanta Hellin-Gil, Judith Jimenez-Veiga, Isabel Alejandra López-Tovar, Ana Morales-Ortiz, José E Meca-Lallana
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study. Neurology and therapy 13 (1) (2023)
Elisabet Lopez-Soley, José E Meca-Lallana, Sara Llufriu, Yolanda Blanco, Rocío Gómez-Ballesteros, Jorge Maurino, Francisco Carlos Pérez-Miralles, Lucía Forero, Carmen Calles, María L Martinez-Gines, Inés González-Suarez, Sabas Boyero, Lucía Romero-Pinel, Ángel P Sempere, Virginia Meca-Lallana, Luis Antonio Querol-Gutiérrez, Lucienne Costa, Maria Sepulveda, Elisabeth Solana
Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder. Journal of personalized medicine 12 (5) (2022)
José E Meca-Lallana, Jorge Maurino, Francisco Pérez-Miralles, Lucía Forero, María Sepúlveda, Carmen Calles, María L Martínez-Ginés, Inés González-Suarez, Sabas Boyero, Lucía Romero-Pinel, Ángel P Sempere, Virginia Meca-Lallana, Luis Querol, Lucienne Costa-Frossard, Daniel Prefasi, Rocío Gómez-Ballesteros, Javier Ballesteros
Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PloS one 16 (7) (2021)
José E Meca-Lallana, Celia Oreja-Guevara, D Muñoz, J Olascoaga, A Pato, L Ramió-Torrentà, V Meca-Lallana, M A Hernández, M E Marzo, J C Álvarez-Cermeño, A Rodríguez-Antigüedad, X Montalbán, Oscar Fernández, null null
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry. PloS one 16 (10) (2021)
José E Meca-Lallana, Juan Antonio García-Merino, Sergio Martínez-Yélamos, Ángela Vidal-Jordana, Lucienne Costa, Alfredo Rodríguez-Antigüedad, Àlex Rovira, Luis Brieva, Eduardo Agüera
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies. Neurodegenerative disease management 11 (3) (2021)